EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Efficacy and safety of combined UV ‐light corneal crosslinking and fine‐needle diathermy to regress pathological murine corneal (lymph)angiogenesis in vivo

Yanhong Hou iD, Wei Zhang, Viet Nhat Hung Le iD, Shuya Deng, Karina Hadrian, Mert Mestanoglu, Gwen Musial, Felix Bock, Claus Cursiefen

Acta Ophthalmologica · 2024

DOI: 10.1111/aos.16696 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Ophthalmologica, 2024. Verfasst von Yanhong Hou und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, University of Cologne, Faculty of Medicine and University Hospital Cologne, Koln, Germany. Hauptthemen laut MEDLINE: Cross-Linking Reagents, Corneal Neovascularization, Diathermy, Photosensitizing Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: EU COST Aniridia, German Research Foundation (DFG) FOR2240 "(Lymph)angiogenesis and Cellular Immunity in Inflammatory Diseases of the Eye", Center for Molecular Medicine Cologne, University of Cologne.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To compare safety and efficacy of isolated and combined UV‐light corneal crosslinking (CXL) and fine‐needle diathermy (FND) to regress pathological corneal vessels in vivo.

Methods

Mice with inflamed and pathologically vascularized corneas received CXL or FND as monotherapy or a combination of both treatments. Corneal pathological blood and lymphatic vessels, immune cells and the morphology of anterior segment structures were evaluated.

Results

All three approaches were able to regress blood and lymphatic vessels in mice. A comparative analysis of the three methods revealed that the FND monotherapy and the CXL + FND combination were significantly more effective than the CXL monotherapy, one and 2 weeks after therapy and especially in regressing lymphatic vessels. Furthermore, the combination therapy induced significantly less immune cell recruitment compared to the monotherapies. All three methods were safe to use in regards of corneal integrity.

Conclusions

A combination of FND and CXL led to regression of pathological corneal lymphatic and blood vessels and reduced the infiltration of immune cells into inflamed murine corneas. This approach offers a new effective, safe and clinically usable strategy to treat eyes with mature pathological blood vessels and even more so for lymphatic vessels, for example prior to high‐risk corneal transplantation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cross-Linking ReagentsCorneal NeovascularizationDiathermyPhotosensitizing AgentsDisease Models, AnimalUltraviolet RaysRiboflavinAnimalsMiceLymphatic VesselsCorneaPhotochemotherapyFemaleMice, Inbred BALB CCombined Modality TherapyLymphangiogenesisMice, Inbred C57BLAngiogenesis

Stichwörter der Autor:innen

UV‐light corneal crosslinkingcorneal angiogenesiscorneal lymphangiogenesisfine‐needle diathermyhigh‐risk corneal transplantation

Substanzen

Cross-Linking ReagentsPhotosensitizing AgentsRiboflavin

Autor:innen und Institutionen

  • Department of Ophthalmology, University of Cologne, Faculty of Medicine and University Hospital Cologne, Koln, Germany.
  • Department of Ophthalmology, Fudan University Eye Ear Nose and Throat Hospital, Shanghai, China.
  • Department of Ophthalmology, Hue College of Medicine and Pharmacy, Hue University, Ho Chi Minh City, Vietnam.
  • Center for Molecular Medicine Cologne (CMMC), University of Cologne, Koln, Germany.
  • CECAD Cluster of Excellence, University of Cologne, Koln, Germany.

ORCID-Profile: Yanhong Hou, Viet Nhat Hung Le

Förderung

  • EU COST Aniridia
  • German Research Foundation (DFG) FOR2240 "(Lymph)angiogenesis and Cellular Immunity in Inflammatory Diseases of the Eye"
  • Center for Molecular Medicine Cologne, University of Cologne
  • Shanghai Sailing Program
  • China Scholarship Council
  • EU Horizon 2020 ARREST BLINDNESS

Zitieren

APA

Hou, Y., Zhang, W., Le, V. N. H., Deng, S., Hadrian, K., Mestanoglu, M., Musial, G., Bock, F., & Cursiefen, C. (2024). Efficacy and safety of combined UV ‐light corneal crosslinking and fine‐needle diathermy to regress pathological murine corneal (lymph)angiogenesis in vivo. Acta Ophthalmologica. https://doi.org/10.1111/aos.16696

Vancouver

Hou Y, Zhang W, Le VNH, Deng S, Hadrian K, Mestanoglu M, et al. Efficacy and safety of combined UV ‐light corneal crosslinking and fine‐needle diathermy to regress pathological murine corneal (lymph)angiogenesis in vivo. Acta Ophthalmologica. 2024. doi:10.1111/aos.16696

BibTeX
@article{Hou2024,
  author = {Hou, Yanhong and Zhang, Wei and Le, Viet Nhat Hung and Deng, Shuya and Hadrian, Karina and Mestanoglu, Mert and Musial, Gwen and Bock, Felix and Cursiefen, Claus},
  title = {Efficacy and safety of combined UV ‐light corneal crosslinking and fine‐needle diathermy to regress pathological murine corneal (lymph)angiogenesis in vivo},
  journal = {Acta Ophthalmologica},
  year = {2024},
  doi = {10.1111/aos.16696}
}
Kostenlos starten →